These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1891766)

  • 21. Repeated doses of oral and subcutaneous heparins have similar antithrombotic effects in a rat carotid arterial model of thrombosis.
    Hiebert LM; Ping T; Wice SM
    J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):110-6. PubMed ID: 21512111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombin-heparin covalent complex: a possible alternative to heparin for arterial thrombosis prevention.
    Chan AK; Rak J; Berry L; Liao P; Vlasin M; Weitz J; Klement P
    Circulation; 2002 Jul; 106(2):261-5. PubMed ID: 12105168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of endogenous plasminogen activator-induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles.
    Hashimoto M; Yamashita T; Oiwa K; Watanabe S; Giddings JC; Yamamoto J
    Thromb Haemost; 2002 Jan; 87(1):110-3. PubMed ID: 11848438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis.
    Heran C; Morgan S; Kasiewski C; Bostwick J; Bentley R; Klein S; Chu V; Brown K; Colussi D; Czekaj M; Perrone M; Leadley R
    Eur J Pharmacol; 2000 Feb; 389(2-3):201-7. PubMed ID: 10688985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study on the in vitro and in vivo activities of heparinoids derivative investigated on the animal model.
    Giedrojć J; Klimiuk M; Radziwon P; Kłoczko J; Bielawiec M; Breddin HK
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):340-5. PubMed ID: 10470990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
    Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
    Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: comparison with unfractionated heparin.
    Sakamoto T; Ogawa H; Takazoe K; Yoshimura M; Shimomura H; Moriyama Y; Arai H; Okajima K
    J Am Coll Cardiol; 2003 Oct; 42(8):1389-94. PubMed ID: 14563580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of external electrical stimulation on laser-beam-induced experimental thrombosis.
    Aguejouf O; Doutremepuich F; Doutremepuich C
    Pathophysiol Haemost Thromb; 2006; 35(5):364-9. PubMed ID: 17230037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
    Imura Y; Stassen JM; Collen D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Orally administered heparins prevent arterial thrombosis in a rat model.
    Pinel C; Wice SM; Hiebert LM
    Thromb Haemost; 2004 May; 91(5):919-26. PubMed ID: 15116252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis.
    McClanahan TB; Hicks GW; Morrison AL; Peng YW; Janiczek-Dolphin N; Mertz TE; Sullivan ME; Morser J; Juneau PL; Leadley R
    Eur J Pharmacol; 2001 Dec; 432(2-3):187-94. PubMed ID: 11740955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic effects of recombinant human soluble thrombomodulin in a rat model of vascular shunt thrombosis.
    Ono M; Nawa K; Marumoto Y
    Thromb Haemost; 1994 Sep; 72(3):421-5. PubMed ID: 7855794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study on the in vivo production of thrombosis in rat mesenteric arterioles and action of prostaglandin (PG) I2 on the thrombosis.
    Takano S; Suzuki T
    Jpn J Pharmacol; 1982 Jun; 32(3):439-44. PubMed ID: 7050479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
    Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
    Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CVS-1123, a direct thrombin inhibitor, prevents occlusive arterial and venous thrombosis in a canine model of vascular injury.
    Rebello SS; Miller BV; Basler GC; Lucchesi BR
    J Cardiovasc Pharmacol; 1997 Feb; 29(2):240-9. PubMed ID: 9057074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
    Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in ex vivo canine arteriovenous shunt model of stent thrombosis.
    Rukshin V; Azarbal B; Finkelstein A; Shah PK; Cercek B; Tsang V; Kaul S
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):615-24. PubMed ID: 12658064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithrombotic effects and bleeding time prolongation with synthetic platelet GPIIb/IIIa inhibitors in animal models of platelet-mediated thrombosis.
    Collen D; Lu HR; Stassen JM; Vreys I; Yasuda T; Bunting S; Gold HK
    Thromb Haemost; 1994 Jan; 71(1):95-102. PubMed ID: 8165652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic effect of a novel recombinant hirudin analogue, CX-397, in a rat arterial thrombosis model.
    Takiguchi Y; Asai F; Wada K; Hayashi H; Nakashima M
    Br J Pharmacol; 1995 Dec; 116(7):3056-60. PubMed ID: 8680743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.